
    
      -  Each treatment cycle lasts four weeks during which time the participant will be taking
           study drug for the first three weeks only. Participants will be supplied with a study
           medication-dosing calendar for each treatment cycle.

        -  Clofarabine is a tablet that will be taken orally in the morning once daily on days 1
           through 21 of each 28-day cycle. Participants can receive up to a total of 6 cycles if
           they do not experience any unacceptable side effects and if their cancer does not get
           worse.

        -  The following tests and procedures will be performed at specified intervals through out
           the treatment period: blood tests, physical examinations, vital signs, radiological
           exams and urine tests.
    
  